Abstract
The in vivo dissolution of enteric-coated (EC) products is often overestimated by compendial in vitro dissolution experiments. It is of great interest to mimic the in vivo conditions as closely as possible in vitro in order to predict the in vivo behavior of EC dosage forms. The reason behind this is the overly high buffering capacity of the common compendial buffers compared to the intestinal bicarbonate buffer. However, a bicarbonate-based buffer is technically difficult to handle due to the need for continuous sparging of the media with CO2 to maintain the desired buffer pH. Therefore, bicarbonate buffers are not commonly used in routine practice and a non-volatile alternative is of interest. A mathematical mass transport modelling approach was previously found to enable accurate calculation of surrogate buffer molarities for small molecule compounds; however, the additional complexity of polymeric materials makes this difficult to achieve for an enteric coat. In this work, an approach was developed allowing relatively rapid screening of potential surrogate buffers for enteric coating. It was found that the effective buffering pKa of bicarbonate at the surface of a dissolving enteric polymer tended to be around 5.5, becoming higher when the dissolving enteric polymer formed a gel of greater firmness/viscosity and vice versa. Using succinate (pKa 5.2 under physiological ionic strength) and/or citrate (pKa 5.7 under physiological ionic strength) at conjugate base molarities corresponding to bicarbonate molarities in the intestinal segments of interest as an initial “guess” can minimize the number of experimental iterations necessary to design an appropriate surrogate.
Highlights
An enteric coating is usually based on a polycarboxylic film former that protects the active pharmaceutical ingredient (API) from degradation in the gastric fluid or reduces the risk of adverse side effects by delaying the drug release until after gastric emptying [1]
After being emptied from the stomach, the enteric-coated (EC) dosage form is exposed to intestinal fluid with increased pH that is mostly buffered by bicarbonate [2,3,4]
Compendial dissolution media for testing of EC dosage forms usually consists of relatively concentrated phosphate buffers [6] compared to intestinal bicarbonate concentrations [7]
Summary
An enteric coating is usually based on a polycarboxylic film former that protects the active pharmaceutical ingredient (API) from degradation in the gastric fluid or reduces the risk of adverse side effects by delaying the drug release until after gastric emptying [1]. The effective apparent pKa at which bicarbonate will buffer the surface of a dissolving ionizable solid (and govern the dissolution rate) will take an intermediate value between the mere carbonic acid ionization value of 3.3 and the bulk equilibrium value of 6.04. Where the D terms are the diffusivities of the species in the subscripts; h is the boundary layer thickness; and kd and kh are the first order rate constants for the H2CO3 dehydration and CO2 hydration reactions, respectively This equation gives pKaeff, the apparent effective buffering pKa in the boundary diffusion layer around a dissolving ionizable solid. As explained later in this manuscript, the more complicated behavior of polymers compared to small molecule compounds makes it difficult to make a direct calculation, this estimate serves as a good starting point in the quest toward a systematic approach to design appropriate surrogate buffers, which is the aim of this work
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.